Retinoblastom

Studienliteratur Retinoblastom

Pubmed

1. Papaioannou K, Kubica R, Fischhuber K, Beygo J, Reschke M, Ritter-Sovinz P, Biewald E, Ketteler P, Lohmann D, Kanber D: MYCN Amplification in RB1-Inactivated Retinoblastoma: Association With High-Risk Features. Pediatric blood & cancer 2026, 73:e70297 [PMID: 41924959] PAP2026
2. Jabbarli L, Göricke S, Stumbaum P, Rating P, Lever M, Kiefer T, Ting S, Junker A, Bornfeld N, Schoenberger S, Bechrakis NE, Ketteler P, Biewald E: Preoperative Detection of Local Tumor Extent in Patients with Advanced Retinoblastoma: Predictive Value of MRI and Clinical Findings. Klinische Monatsblatter fur Augenheilkunde 2025, 242: 1122 [PMID: 38134910] JAB2025
3. Bielefeld C, Hugo T, Sievers N, Ketteler P, Biewald E, Kiefer T, Papaioannou K, Tüller P, Ryl T, Busch M, Rawitzer J, Schildhaus HU, Ting S: Definition of parameters and thresholds to detect MYCN amplification in retinoblastomas. Virchows Archiv : an international journal of pathology 2025, [PMID: 40839307] BIE2025
4. de Bloeme CM, Jansen RW, de Haan J, Pieperjohanns D, Casseri T, Gironi F, Pasca A, Ketteler P, Moll AC, Koob M, Sirin S, Maeder P, Galluzzi P, Göricke S, de Graaf P, de Jong MC, European Retinoblastoma Imaging Collaboration: Follow-up of Cystic Pineal Glands in Retinoblastoma Patients Does Not Increase Detection of Pineal Trilateral Retinoblastoma. American journal of ophthalmology 2024, 268: 199 [PMID: 38992673] BLO2024
5. Lavasidis G, Papaioannou K, Anagnostou N, Ketteler P, Bechrakis NE, Ntzani E: Evidence in Focus: The Sparse Landscape of Randomized Trials on Retinoblastoma Treatment. Ocular oncology and pathology 2024, 10: 53 [PMID: 38751498] LAV2024
6. Ryl T, Afanasyeva E, Hartmann T, Schwermer M, Schneider M, Schröder C, Wagemanns M, Bister A, Kanber D, Steenpass L, Schramm K, Jones B, Jones DTW, Biewald E, Astrahantseff K, Hanenberg H, Rahmann S, Lohmann DR, Schramm A, Ketteler P: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications biology 2024 Jul 30; 7: 919 [PMID: 39079981] RYL2024
7. Al-Ghazzawi K, Wessolly M, Dalbah S, Ketteler P, Kiefer T, Bechrakis N, Leyla J, Ting S, Biewald E, Mairinger FD: PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma. Frontiers in oncology 2023, 13: 1144951 [PMID: 37965463] ALG2023
8. Diarra Y, Brockmeyer C, Fischhuber K, Hülsenbeck I, Ting S, Reschke M, Kiefer T, Hannbücken A, Wagemanns M, Jabbarli L, Sirin S, Wieland R, Fleischhack G, Schulte JH, Ebinger M, Lohmann D, Müller B, Süsskind D, Schwab C, Brecht I, Eggert A, Schönberger S, Ritter-Sovinz P, Bechrakis N, Göricke S, Timmermann B, Biewald E, Ketteler P: Adjuvant therapy for children treated by enucleation at diagnosis of retinoblastoma. EJC paediatric oncology 2023, 1:None [PMID: 40061040] DIA2023
9. Bouchoucha Y, Matet A, Berger A, Carcaboso AM, Gerrish A, Moll A, Jenkinson H, Ketteler P, Dorsman JC, Chantada G, Beck-Popovic M, Munier F, Aerts I, Doz F, Golmard L, European Retinoblastoma Group EuRbG: Retinoblastoma: From genes to patient care. European journal of medical genetics 2023, 66: 104674 [PMID: 36470558] BOU2023
10. Schweiger B, Göricke S, Ketteler P, Biewald E, Kottke R, Sirin S: [Imaging of retinoblastoma : Current state-of-the-art and future prospects]. Radiologie (Heidelberg, Germany) 2022, 62: 1067 [PMID: 35969246] SCH2022c
11. Schlüter S, Bornfeld N, Valiyev E, Flühs D, Stuschke M, Bechrakis NE, Kiefer T, Ketteler P, Göricke S, Biewald EM: Combination of Brachytherapy and Intravitreal Chemotherapy in the Treatment of Retinoblastoma with Vitreous Seeding. Ocular oncology and pathology 2022, 8: 64 [PMID: 35356603] SCH2022a
12. Rating P, Bornfeld N, Schlüter S, Westekemper H, Kiefer T, Stuschke M, Göricke S, Ketteler P, Ting S, Metz KA, Bechrakis NE, Biewald E: Long-Term Results after Intraocular Surgery in Treated Retinoblastoma Eyes. Ocular oncology and pathology 2022, 8: 161 [PMID: 36938377] RAT2022
13. Maricic N, Schwermer M, Schramm A, Morosan-Puopolo G, Ketteler P, Brand-Saberi B: Zebrafish as an Orthotopic Tumor Model for Retinoblastoma Mimicking Routes of Human Metastasis. Cancers 2022, 14 [PMID: 36497295] MAR2022
14. Grümme L, Biewald E, Reschke M, Fischhuber K, Hanbücken A, Schlüter S, Müller B, Kiefer T, Göricke S, Geismar D, Ryl T, Sirin S, Wieland R, Timmermann B, Lohmann D, Ebinger M, Brecht IB, Schönberger S, Schwab C, Eggert A, Süsskind D, Ritter-Sovinz P, Bechrakis NE, Ketteler P: Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatric blood & cancer 2022, 69:e29362 [PMID: 34606174] GRU2022
15. Biewald E, Kiefer T, Geismar D, Schlüter S, Manthey A, Westekemper H, Wulff J, Timmermann B, Ketteler P, Schönberger S, Metz KA, Ting S, Göricke S, Bechrakis NE, Bornfeld N: Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes. Cancers 2021 Apr 13; 13 [PMID: 33924716] BIE2021a
16. Opitz M, Bos D, Deuschl C, Radbruch A, Zensen S, Sirin S, Forsting M, Bechrakis N, Biewald E, Bornfeld N, Ketteler P, Timmermann B, Stuschke M, Guberina M, Wetter A, Göricke S, Guberina N: Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success. Neuroradiology 2021, 63: 391 [PMID: 32862237] OPI2021
17. Reschke M, Biewald E, Bronstein L, Brecht IB, Dittner-Moormann S, Driever F, Ebinger M, Fleischhack G, Grabow D, Geismar D, Göricke S, Guberina M, Le Guin CHD, Kiefer T, Kratz CP, Metz K, Müller B, Ryl T, Schlamann M, Schlüter S, Schönberger S, Schulte JH, Sirin S, Süsskind D, Timmermann B, Ting S, Wackernagel W, Wieland R, Zenker M, Zeschnigk M, Reinhardt D, Eggert A, Ritter-Sovinz P, Lohmann DR, Bornfeld N, Bechrakis N, Ketteler P: Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria. Cancers 2021 Apr 14; 13 [PMID: 33919815] RES2021
18. Hülsenbeck I, Frank M, Biewald E, Kanber D, Lohmann DR, Ketteler P: Introduction of a Variant Classification System for Analysis of Genotype-Phenotype Relationships in Heritable Retinoblastoma. Cancers 2021 Mar 31; 13 [PMID: 33807189] HUE2021
19. Kiefer T, Schlüter S, Bechrakis NE, Bornfeld N, Göricke S, Ketteler P, Ting S, Geismar D, Biewald E: Intraarterial Chemotherapy for Retinoblastoma - Initial Experiences of a German Reference Centre. Klinische Monatsblatter fur Augenheilkunde 2021, 238: 788 [PMID: 34376009] KIE2021
20. Dittner-Moormann S, Reschke M, Abbink FCH, Aerts I, Atalay HT, Fedorovna Bobrova N, Biewald E, Brecht IB, Caspi S, Cassoux N, Castela G, Diarra Y, Duncan C, Ebinger M, Garcia Aldana D, Hadjistilianou D, Kepák T, Klett A, Kiratli H, Maka E, Opocher E, Pawinska-Wasikowska K, Rascon J, Russo I, Rutynowska-Pronicka O, Sábado Álvarez C, Pacheco SSR, Svojgr K, Timmermann B, Vishnevskia-Dai V, Eggert A, Ritter-Sovinz P, Bechrakis NE, Jenkinson H, Moll A, Munier FL, Popovic MB, Chantada G, Doz F, Ketteler P: Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatric blood & cancer 2021, 68:e28963 [PMID: 33720495] DIT2021
21. Ketteler P, Hülsenbeck I, Frank M, Schmidt B, Jöckel KH, Lohmann DR: The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma. European journal of cancer (Oxford, England : 1990) 2020, 133: 47 [PMID: 32434110] KET2020
22. Bornfeld N, Biewald E, Bauer S, Temming P, Lohmann D, Zeschnigk M: The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors. Deutsches Arzteblatt international 2018 Feb 16; 115: 106 [PMID: 29510820] BOR2018
23. Temming P, Eggert A: Retinoblastom, in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH Deutschland 2018 [ISBN: 978-3-662-43686-8] TEM2018
24. Schwermer M, Dreesmann S, Eggert A, Althoff K, Steenpass L, Schramm A, Schulte JH, Temming P: Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines. Clinical & experimental ophthalmology 2017, 45: 288 [PMID: 27647547] SCH2017a
25. Temming P, Arendt M, Viehmann A, Eisele L, Le Guin CH, Schündeln MM, Biewald E, Astrahantseff K, Wieland R, Bornfeld N, Sauerwein W, Eggert A, Jöckel KH, Lohmann DR: Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center. Pediatric blood & cancer 2017, 64: 71 [PMID: 27567086] TEM2017
26. Sirin S, de Jong MC, de Graaf P, Brisse HJ, Galluzzi P, Maeder P, Bornfeld N, Biewald E, Metz KA, Temming P, Castelijns JA, Goericke SL, European Retinoblastoma Imaging Collaboration: High-Resolution Magnetic Resonance Imaging Can Reliably Detect Orbital Tumor Recurrence after Enucleation in Children with Retinoblastoma. Ophthalmology 2016, 123: 635 [PMID: 26692298] SIR2016
27. Temming P, Arendt M, Viehmann A, Eisele L, Le Guin CH, Schündeln MM, Biewald E, Mäusert J, Wieland R, Bornfeld N, Sauerwein W, Eggert A, Lohmann DR, Jöckel KH: How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Jul 5; [PMID: 27382102] TEM2016
28. Schündeln MM, Hauffa PK, Bauer JJ, Temming P, Sauerwein W, Biewald E, Bornfeld N, Hauffa BP, Grasemann C: Pediatric Survivors of Retinoblastoma Are at Risk for Altered Bone Metabolism After Chemotherapy Treatment Early in Life. Pediatric hematology and oncology 2015, 32: 455 [PMID: 26237585] SCH2015c
29. Temming P, Viehmann A, Arendt M, Eisele L, Spix C, Bornfeld N, Sauerwein W, Jöckel KH, Lohmann DR: Pediatric second primary malignancies after retinoblastoma treatment. Pediatric blood & cancer 2015, 62: 1799 [PMID: 25970657] TEM2015
30. Künkele A, Wilm J, Holdt M, Lohmann D, Bornfeld N, Eggert A, Temming P, Schulte JH: Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre. The British journal of ophthalmology 2015,Epub ahead of print [PMID: 25583279] KUE2015
31. Temming P, Eggert A, Bornfeld N, Sauerwein W, Göricke S, Lohmann DR: [Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of vision]. Klinische Monatsblatter fur Augenheilkunde 2013, 230: 232 [PMID: 23508752] TEM2013a
32. Temming P, Viehmann A, Biewald E, Lohmann DR: Sporadic unilateral retinoblastoma or first sign of bilateral disease? Br J Ophthalmol 2013, 97: 475 [PMID: 23355526] TEM2013
33. Temming P, Corson TW, Lohmann DR: Retinoblastoma tumorigenesis: genetic and epigenetic changes walk hand in hand. Future oncology (London, England) 2012, 8: 525 [PMID: 22646767] TEM2012
34. Wieland R, Havers W: Retinoblastome. In: Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag 2006, 823 [ISBN: 3540037020] WIE2004
35. Kremens B, Wieland R, Reinhard H, Neubert D, Beck JD, Klingebiel T, Bornfeld N, Havers W: High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone marrow transplantation 2003, 31: 281 [PMID: 12621463] KRE2003a